Related Articles
Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients
Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer
Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer.